IMPROVING ONCOLOGY RESEARCH WITH BUILT-IN KRAS ASSAY EXPERT SERVICES AND RAS ASSAYS

within the promptly evolving field of oncology study, exact and effective mutation screening is crucial for producing targeted therapies. The KRAS products and services Platform performs a pivotal purpose With this landscape by offering extensive methods for KRAS mutation profiling and Examination. KRAS mutations, located in about 95% of RAS-linked